{"schema_version":"secwatch.filing_event.v1","accession":"0000897101-23-000503","form_type":"8-K","ticker":"ELMD","cik":"0001488917","company_name":"Electromed, Inc.","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.221427+00:00","generated_at":"2026-06-08T02:16:52.782077+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Electromed shareholders elect eight directors and approve equity plan at annual meeting","bullets":["All eight director nominees elected; average 'For' votes ~3.9M, broker non-votes 1.28M.","2023 Equity Incentive Plan approved: 3.90M For, 147K Against, 19.8K Abstain.","RSM US LLP ratified as independent auditor for FY2024: 5.26M For, 44.8K Against.","Advisory vote on executive compensation approved: 3.99M For, 54.9K Against."],"urls":{"canonical":"https://secwatch.observer/filing/0000897101-23-000503","json":"https://secwatch.observer/filing/0000897101-23-000503.json","markdown":"https://secwatch.observer/filing/0000897101-23-000503.md","text":"https://secwatch.observer/filing/0000897101-23-000503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/0000897101-23-000503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/elmd231171_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T02:16:52.782077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"066f4e772bf7c1be854337b285f16c5dec25c3bb","claim":"Electromed, Inc. shareholders approved Election of directors for a one-year term at the 2023-11-10 meeting.","evidence_excerpt":"At the annual meeting of shareholders of Electromed, Inc. (the “Company”) held on November 10, 2023, the following proposals, each as described in further detail in the definitive proxy statement filed on September 26, 2023 , were voted upon by our shareholders as set forth below: 1. The following individuals designated by our Board of Directors (the “Board”) as nominees for director were elected for a one-year term or until a successor has been elected and qualified, thereby setting the number of directors at eight, with voting as follows: Name For Withheld Broker Non-Votes James L. Cunniff 4,043,526 23,776 1,282,424 Stan K. Erickson 3,934,581 132,721 1,282,424 Gregory J. Fluet 3,886,683 180,619 1,282,424 Joseph L. Galatowitsch 4,036,919 30,383 1,282,424 Kathleen S. Skarvan 4,026,909 40,393 1,282,424 Andrew J. Summers 3,308,087 759,215 1,282,424 Kathleen A. Tune 3,416,625 650,677 1,282,424 Andrea M. Walsh 3,928,188 139,114 1,282,424","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/0000897101-23-000503-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"626f1c794dd8c98627e99eb63e022c69d299aabf","claim":"Electromed, Inc. shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending June 30, 2024 at the 2023-11-10 meeting.","evidence_excerpt":"3. Our shareholders ratified the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024, with voting as follows: For Against Abstain 5,256,837 44,804 48,085","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/0000897101-23-000503-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"730cd654b56ca70208d9bb65828044fc2e6468bd","claim":"Electromed, Inc. shareholders approved Approval of the Electromed, Inc. 2023 Equity Incentive Plan at the 2023-11-10 meeting.","evidence_excerpt":"2. Our shareholders approved the Electromed, Inc. 2023 Equity Incentive Plan with voting as follows: For Against Abstain Broker Non-Votes 3,900,794 146,689 19,819 1,282,424","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/0000897101-23-000503-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"e171910e7322ecc30b4c4cafb1eba8da161d2e3d","claim":"Electromed, Inc. shareholders approved Non-binding advisory vote on executive compensation at the 2023-11-10 meeting.","evidence_excerpt":"4. Our shareholders approved, on a non-binding and advisory basis, our executive compensation, with voting as follows: For Against Abstain Broker Non-Votes 3,990,197 54,887 22,218 1,282,424","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000089710123000503/0000897101-23-000503-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}